Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China flag China · Delayed Price · Currency is CNY
32.16
+0.34 (1.07%)
Feb 3, 2026, 3:04 PM CST

SHE:002940 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
602.24697.38859.75735.47688.91854.07
Trading Asset Securities
187.336.041069.359.6-
Cash & Short-Term Investments
789.54733.42869.75804.76748.51854.07
Cash Growth
-11.77%-15.68%8.08%7.52%-12.36%36.05%
Accounts Receivable
183.01234.32244.86295.51301.32259.8
Other Receivables
1.339.8521.456.7717.2711.44
Receivables
184.34244.18266.31302.28318.59271.24
Inventory
467.95503.79393.44293.23299.6263
Other Current Assets
19.9817.4832.4351.699.255.09
Total Current Assets
1,4621,4991,5621,4521,3761,393
Property, Plant & Equipment
593.49603.86615.8445.7474.63389.51
Long-Term Investments
306.15304.7301.41302.15147.3494.99
Goodwill
312.94312.94312.9421.9821.98-
Other Intangible Assets
126.07133.55139.1438.7840.0536.88
Long-Term Deferred Tax Assets
46.0750.0632.7722.4420.6522.88
Long-Term Deferred Charges
54.3249.4835.060.981.61.57
Other Long-Term Assets
20.6621.0720.95312.091.361.53
Total Assets
2,9222,9753,0202,5962,0841,941
Accounts Payable
449.84485.45402.49320.45335.97322.73
Accrued Expenses
33.35120.24130.41220.56218.67182.3
Short-Term Debt
137.82163.37134.9171.941.7611.77
Current Portion of Long-Term Debt
32.2220.2130.425.02--
Current Portion of Leases
--0.26---
Current Income Taxes Payable
13.715.579.34-2.889.18
Current Unearned Revenue
9.4132.3118.7241.6731.917.47
Other Current Liabilities
92.0816.395.458.954.11.74
Total Current Liabilities
768.42843.54731.97788.59595.29545.19
Long-Term Debt
298.35303.5423.95150--
Long-Term Unearned Revenue
17.816.7817.859.7313.317.59
Long-Term Deferred Tax Liabilities
11.2412.2913.951.60.06-
Total Liabilities
1,0961,1761,188949.93608.64562.78
Common Stock
201.73201.73201.73139.1295.9595.95
Additional Paid-In Capital
700.48684.01723.84782.91824.87816.25
Retained Earnings
766.08712.9674.51577.87478.74405.84
Treasury Stock
-84.1-74.5-20.12--63.34-
Comprehensive Income & Other
9.716.46.252.752.640.84
Total Common Equity
1,5941,5311,5861,5031,3391,319
Minority Interest
231.84267.87246.07143.5136.0859.09
Shareholders' Equity
1,8261,7981,8321,6461,4751,378
Total Liabilities & Equity
2,9222,9753,0202,5962,0841,941
Total Debt
468.38487.08589.52346.961.7611.77
Net Cash (Debt)
321.16246.34280.23457.8746.75842.3
Net Cash Growth
-2.60%-12.10%-38.79%-38.69%-11.34%34.55%
Net Cash Per Share
1.601.231.402.303.744.43
Filing Date Shares Outstanding
196.11196.89199.71197.4197.4201.73
Total Common Shares Outstanding
196.11196.89199.71197.4197.4201.73
Working Capital
693.4655.33829.96663.37780.67848.21
Book Value Per Share
8.137.777.947.616.786.54
Tangible Book Value
1,1551,0841,1341,4421,2771,282
Tangible Book Value Per Share
5.895.515.687.306.476.36
Buildings
-447.5435.42314.48319.46196.09
Machinery
-640.01628.95467.67439.73344.29
Construction In Progress
-49.622.5225.3329.94113.07
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.